je.st
news
Eli Lilly and Co (LLY) Lifted to "Outperform" at Credit Suisse
2015-12-13 16:47:40| Biotech - Topix.net
The brokerage presently has a $105.00 price target on the stock. Credit Suisse's price objective suggests a potential upside of 26.07% from the stock's previous close.
Tags: credit
suisse
eli
lifted
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||